ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 156,53
0,43%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. RAPT Therapeutics Inc (RAPT)

  7. RAPT Therapeutics Inc (RAPT) Actualités

RAPT RAPT Therapeutics Inc

8,30
0,175 (2,15%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
RAPT Therapeutics Inc RAPT NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,175 2,15% 8,30 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
8,28 8,15 8,58 8,33 8,125
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
09/4/202418:00GLOBERAPT Therapeutics Announces Promising Results from Phase 2..
07/3/202422:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/3/202414:08EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202414:03EDGAR2Form 8-K - Current report
07/3/202414:00GLOBERAPT Therapeutics Reports Fourth Quarter and Full Year 2023..
05/3/202422:30GLOBERAPT Therapeutics Announces Multiple Late-Breaking..
22/2/202423:13EDGAR2Form 8-K - Current report
20/2/202422:29EDGAR2Form 8-K - Current report
20/2/202413:30GLOBERAPT Therapeutics Announces Clinical Hold on Studies..
14/2/202414:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202414:00GLOBERAPT Therapeutics Bolsters Leadership Team with the..
31/1/202414:00GLOBERAPT Therapeutics to Participate in the Guggenheim..
02/1/202414:00GLOBERAPT Therapeutics to Present at the 42nd Annual J.P. Morgan..
27/11/202314:00GLOBERAPT Therapeutics Announces Publication of Phase 1a/1b..
13/11/202314:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202314:03EDGAR2Form 8-K - Current report
13/11/202314:00GLOBERAPT Therapeutics Reports Third Quarter 2023 Financial..
03/11/202317:03EDGAR2Form 8-K - Current report
03/11/202317:00GLOBERAPT Therapeutics Announces Positive Data, Including..
01/11/202321:05GLOBERAPT Therapeutics to Participate in Several Upcoming..
18/10/202315:00GLOBERAPT Therapeutics Announces Two FLX475 Presentations at the..
30/8/202322:05GLOBERAPT Therapeutics to Participate in Several Upcoming..
18/8/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
11/8/202322:02EDGAR2Form 8-K - Current report
11/8/202314:57EDGAR2Form S-3 - Registration statement under Securities Act of..
11/8/202314:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202314:05EDGAR2Form 8-K - Current report
11/8/202314:00GLOBERAPT Therapeutics Reports Second Quarter 2023 Financial..
07/6/202314:00GLOBERAPT Therapeutics to Participate in the Goldman Sachs Global..
25/5/202323:00GLOBERAPT Therapeutics to Present Biomarker Data Corroborating..
11/5/202314:00GLOBERAPT Therapeutics Reports First Quarter 2023 Financial..

Dernières Valeurs Consultées

NASDAQ
RAPT
RAPT Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés